Related Experiment Video

Updated: Aug 16, 2026

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices
06:36

An Ex vivo Model of an Oligodendrocyte-directed T-Cell Attack in Acute Brain Slices

Published on: February 5, 2015

Programmed cell death of myelin basic protein-specific T lymphocytes is reduced in patients with acute multiple

Marina Saresella1, Ivana Marventano, Livianna Speciale

  • 1Laboratory of Molecular Medicine and Biotechnology, IRCCS S. Maria Nascente, Don C. Gnocchi Foundation, 66, Milan, Italy.

Journal of Neuroimmunology
|September 15, 2005
PubMed

Insights

In multiple sclerosis (MS) patients with acute MS, myelin basic protein (MBP)-specific T cells show reduced apoptosis. This impaired T-cell death may contribute to the immune-mediated myelin sheath destruction characteristic of acute MS.

Area of Science:

  • Neuroimmunology
  • Cellular Immunology
  • Autoimmune Diseases

Background:

  • Multiple sclerosis (MS) is an autoimmune disease targeting the central nervous system.
  • T lymphocytes play a critical role in the immunopathology of MS.
  • Understanding T-cell apoptosis in MS is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the apoptosis of myelin basic protein (MBP)-specific T lymphocytes in patients with acute MS (AMS) and stable MS (SMS).
  • To compare T-cell apoptosis rates between MS patients and healthy controls (HC).
  • To explore the potential role of altered T-cell apoptosis in the pathogenesis of AMS.

Main Methods:

  • Evaluation of apoptosis markers on peripheral blood cells from AMS, SMS patients, and HC.
  • Assessment of mitogen-stimulated and MBP-stimulated apoptosis in CD4+ and CD8+ T lymphocytes.
  • Quantification of 7-AAD+ and 7-AAD+ Fas+ cells as indicators of apoptosis.

Main Results:

  • Mitogen-stimulated apoptosis was similar across all groups (AMS, SMS, HC).
  • MBP-stimulated CD4+ and CD8+ T lymphocytes expressing 7-AAD+ and 7-AAD+ Fas+ (apoptotic cells) were significantly reduced in AMS patients compared to SMS and HC.
  • A reduced apoptotic rate of myelin-specific T lymphocytes was observed in AMS.

Conclusions:

  • A reduced rate of apoptosis in myelin-specific CD4+ and CD8+ T lymphocytes may be implicated in the immune-mediated destruction of the myelin sheath in AMS.
  • These findings highlight a potential mechanism contributing to disease activity in acute multiple sclerosis.
  • Targeting T-cell apoptosis pathways could represent a therapeutic strategy for AMS.

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...